110 likes | 211 Views
HIV/AIDS communities and AIDS vaccine research. AIDES / TRT-5 Tour Essor 14, rue Scandicci 93508 Pantin Cedex. Questions from the community. ANRS and vaccine trials of therapeutic vaccines ANRS and recruitment of HIV-volunteers to participate to vaccine trials (safety issues raised)
E N D
HIV/AIDS communities and AIDS vaccine research AIDES / TRT-5 Tour Essor 14, rue Scandicci 93508 Pantin Cedex
Questions from the community • ANRS and vaccine trials of therapeutic vaccines • ANRS and recruitment of HIV-volunteers to participate to vaccine trials (safety issues raised) • Partnership with African NGOs (Réseau Afrique 2000): how far are we from a vaccine? • To stop the spread of AIDS
To be better informed • TRT-5 first met • with the ANRS investigators (1999) • Aventis (Alvac) in 1999 • Attendance to scientific meetings • Internal training sessions (immunologists)
To inform • Press releases after the announcement of the results of the ANRS trials • Press release after AIDSVAX results
To link up • Vaccine Working Group • IAVI partnership • Microbicides initiative
To work with • ANRS • AC5 Clinical trials: to have two community representatives (voting rights) • AC28 Preventive vaccines: two community representatives (one from the HIV community and one from the volunteers) • Modification of design of clinical trials • Set up of the long term follow up of vaccinees
To lobby • Towards the Industry to have access to vaccine preparation (Aventis supplied Orvéac with ALVAC after a TRT-5 meeting) • Authorities to maintain a strong commitment to prolong the ANRS • Within the ANRS, AC28 to finally do a proper work!
To lobby • Within our organization for preventive technologies to be a priority • EU for commitment • French government to pursue funding for a preventive vaccine. Does it have to be only directed to the ANRS?